Enanta Pharmaceuticals Inc (ENTA): Free Cash Flow
-$32.17M
Year ended 2025-09-30
-$36.94M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | -$32.17M | n/m | 2025-11-19, From 2024-10-01 |
| 2024-09-30 | -$96.71M | n/m | 2025-11-19, From 2023-10-01 |
| 2023-09-30 | -$112.21M | n/m | 2025-11-19, From 2022-10-01 |
| 2022-09-30 | -$86.91M | n/m | 2024-11-27, From 2021-10-01 |
| 2021-09-30 | -$70.75M | n/m | 2023-11-22, From 2020-10-01 |
| 2020-09-30 | $5.64M | -91.5% | 2022-11-23, From 2019-10-01 |
| 2019-09-30 | $66.00M | +151.5% | 2021-11-24, From 2018-10-01 |
| 2018-09-30 | $26.24M | -47.7% | 2020-11-25, From 2017-10-01 |
| 2017-09-30 | $50.15M | +61.4% | 2019-11-27, From 2016-10-01 |
| 2016-09-30 | $31.07M | -58.2% | 2018-11-29, From 2015-10-01 |
| 2015-09-30 | $74.34M | +288.2% | 2017-12-11, From 2014-10-01 |
| 2014-09-30 | $19.15M | +90.6% | 2016-12-09, From 2013-10-01 |
| 2013-09-30 | $10.05M | -55.1% | 2015-12-11, From 2012-10-01 |
| 2012-09-30 | $22.37M | -5.1% | 2014-12-11, From 2011-10-01 |
| 2011-09-30 | $23.57M | n/a | 2013-12-18, From 2010-10-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Enanta Pharmaceuticals Inc (ENTA) | 2025-09-30 | -$32.17M | n/m |
| Fortress Biotech, Inc. (FBIO) | 2024-12-31 | -$80.19M | n/m |
| Kura Oncology, Inc. (KURA) | 2025-12-31 | -$70.70M | n/m |
| Tango Therapeutics, Inc. (TNGX) | 2025-12-31 | -$139.93M | n/m |
| Rockwell Medical, Inc. (RMTI) | 2025-12-31 | -$1.20M | n/m |
| Journey Medical Corp (DERM) | 2024-12-31 | -$24.13M | n/m |
| Viridian Therapeutics, Inc. (VRDN) | 2025-12-31 | -$276.89M | n/m |
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | -$41.16M | n/m |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | -$252.03M | n/m |
Compare ENTA, FBIO, KURA, TNGX side by side · Screen every company in Pharmaceutical Preparations ↗